Edward Garmey Lecturing at Harvard Medical School on Checkpoint Inhibitors

Edward Garmey MD, Alacrita Consultant, is lecturing at Harvard Medical School on June 23.

Edward’s lecture, titled “Checkpoint inhibitors in the treatment of cancer” will present CPIs as a model for harnessing and enabling the body’s immune system in the war against cancer.

The lecture is part of a course to introduce translational medicine to MD and PhD students and will specifically focus on the investigation of how unmet medical needs are identified and addressed.

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Stay in touch